Can an adult with hypertension who is not taking nitroglycerin or phosphodiesterase‑5 inhibitors and has no history of kidney stones or severe oxalate intolerance safely use beetroot juice to lower blood pressure, and what dosage regimen is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beetroot Juice for Blood Pressure Management

Beetroot juice can be recommended as a supplementary dietary intervention for adults with hypertension, with an expected systolic blood pressure reduction of approximately 4-5 mmHg when consuming 250 mL daily (containing ~400 mg nitrate), though it should complement—not replace—established first-line interventions like the DASH diet, sodium reduction, and weight loss.

Guideline Context and Evidence Hierarchy

The ACC/AHA guidelines do not specifically endorse beetroot juice as a primary intervention, instead categorizing it among interventions with less persuasive clinical trial evidence compared to the "big six" proven strategies 1. However, the American Heart Association recognizes beetroot juice as a supplementary intervention for untreated hypertensive patients, pre-hypertensive individuals, and those seeking additional dietary interventions 2.

Evidence for Blood Pressure Reduction

Magnitude of Effect

  • Hypertensive individuals experience approximately 4-5 mmHg systolic blood pressure reduction with beetroot juice supplementation 2, 3
  • This effect is comparable to alcohol moderation (4 mmHg reduction) but less than the DASH diet (11 mmHg in hypertensives) or sodium reduction (5-6 mmHg) 1

Quality of Evidence

The most robust clinical trial data comes from a 2015 British Heart Foundation-funded randomized controlled trial showing:

  • 7.7/5.2 mmHg reduction in 24-hour ambulatory BP with 250 mL daily beetroot juice (containing dietary nitrate) over 4 weeks 4
  • Sustained effect without tachyphylaxis over the intervention period 4
  • Improved endothelial function by ~20% and reduced arterial stiffness 4

Critical caveat: A contradictory 2015 study found no blood pressure reduction in patients already on antihypertensive medications, despite demonstrating 3-fold increases in plasma nitrite/nitrate 5. This suggests beetroot juice may be most effective in untreated or uncontrolled hypertension rather than as an add-on to optimized pharmacotherapy.

Recommended Dosing Regimen

250 mL daily of beetroot juice containing approximately 400 mg nitrate 4, 6

  • This translates to roughly 12.9 mmol nitrate per day 7
  • Duration: Minimum 4 weeks to assess sustained benefit 4
  • Timing: Can be taken at any convenient time to establish habitual pattern 1

Patient Selection Algorithm

Best Candidates (Strongest Evidence):

  1. Untreated hypertensive patients (drug-naive) 4
  2. Uncontrolled hypertension despite lifestyle modifications 7
  3. Pre-hypertensive individuals (BP 120-139/70-89 mmHg) seeking dietary interventions 2
  4. Overweight/obese hypertensives who may experience greater benefits 3

Requires Caution:

  • Patients already on antihypertensive medications: Must consult healthcare provider due to potential additive hypotensive effects 2, 3
  • Kidney disease patients: Exercise caution with high-nitrate supplements due to potential potassium content and impaired nitrate metabolism 2, 3
  • Patients with history of kidney stones or severe oxalate intolerance: Beetroot is high in oxalates (not explicitly addressed in guidelines but clinically relevant)

Contraindications:

  • Concurrent nitroglycerin or PDE-5 inhibitor use: Risk of severe hypotension (standard nitrate precaution, though not explicitly stated in beetroot literature)

Integration with Established Interventions

Beetroot juice should never be positioned as a first-line intervention but rather as a complementary strategy alongside proven interventions 1:

Priority Hierarchy (Based on BP Reduction):

  1. DASH diet: 11 mmHg systolic reduction in hypertensives 1
  2. Sodium reduction to <1500 mg/day: 5-6 mmHg reduction 1
  3. Weight loss: ~1 mmHg per kg lost 1
  4. Potassium supplementation (3500-5000 mg/day): 4-5 mmHg reduction 1
  5. Aerobic exercise (150 min/week): 5-8 mmHg reduction 1
  6. Alcohol moderation: 4 mmHg reduction 1
  7. Beetroot juice: 4-5 mmHg reduction (supplementary) 2, 4

Mechanism of Action

Beetroot juice works through the nitrate/nitrite/nitric oxide (NO₃⁻/NO₂⁻/NO) pathway, increasing NO-mediated vasodilation 8, 4. This mechanism is particularly relevant in ADPKD patients with impaired NO synthesis 6, though this represents a specialized population.

Practical Implementation

  • Cost-effectiveness: Beetroot juice is an affordable, readily-available intervention 8, 4
  • Tolerability: Generally well-tolerated in clinical trials 4
  • Monitoring: Track home BP readings during the first 2-4 weeks to assess individual response 4
  • Nutritional benefits: Provides phytonutrients including carotenoids, potassium, vitamins A and C 3
  • Limitation: Provides less fiber than whole vegetables 3

Critical Clinical Pitfall

Do not delay or replace indicated antihypertensive medication in patients with stage 2 hypertension (≥140/90 mmHg) or those with cardiovascular risk factors requiring pharmacotherapy 9. The evidence for beetroot juice is insufficient to justify monotherapy in patients who meet criteria for pharmacological treatment per ACC/AHA guidelines 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.